Press releases

Orchard Therapeutics Ltd. Announces a Manufacturing Services Agreement with PCT Cell Therapy Services, LLC

Orchard Therapeutics Limited announces on May 30th that it has entered a new clinical manufacturing services agreement with PCT Cell Therapy Services, LLC (“PCT”), a Hitachi Group Company

Read more

Orchard Therapeutics Ltd. Announces a Manufacturing Alliance with PharmaCell B.V.

Orchard Therapeutics announces today an alliance with PharmaCell B.V. (“PharmaCell”), a leading Contract Manufacturing Organization (CMO) for Cell and Gene Therapies and Regenerative Medicine

Read more

Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica

Orchard Therapeutics announces today that it has entered into a strategic alliance with Oxford BioMedica plc, a world-leading company in gene and cell therapy

Read more

Orchard Therapeutics and UCLA receive $19 million in latest round of funding from California’s stem cell agency

Orchard Therapeutics Limited and researchers from the UCLA Broad Stem Cell Research Center, led by Orchard Scientific Advisory Board member Dr. Donald Kohn have been awarded $19 million by the California Institute for Regenerative Medicine’s governing board (CIRM)

Read more

Dr Andrea Spezzi named one of BioBeat Movers and Shakers in the BioBusiness report - 2016

Dr Andrea Spezzi, CMO, R&D Head and co-founder of Orchard Therapeutics, has been named as one of the women changing the face and future of healthcare in the BioBeat 50 Movers and Shakers in the BioBusiness 2016 report

Read more